WASHINGTON, Oct 22 (Reuters) - Pfizer Inc’s smoking-cessation drug Chantix should carry a strong warning about the potential risks of accidental injury and death, U.S. researchers said on Wednesday.
WASHINGTON, Oct 22 (Reuters) - Pfizer Inc’s smoking-cessation drug Chantix should carry a strong warning about the potential risks of accidental injury and death, U.S. researchers said on Wednesday.
